PROGNOSTIC SIGNIFICANCE OF ENDOTHELIAL DYSFUNCTION MARKERS IN ARTERIAL HYPERTENSION

PROGNOSTIC SIGNIFICANCE OF ENDOTHELIAL DYSFUNCTION MARKERS IN ARTERIAL HYPERTENSION

Aim. Assessment of prognostic significance of endothelial dysfunction markers: stable metabolites of nitric oxide (NOx), von Willebrand factor (vWF), endothelin-1 (E1), homocysteine and tissue plasminogen activator (tPA) in essential hypertension (EAH) patients not taking antihypertension therapy sy...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. I. Podzolkov, A. E. Bragina, N. A. Bragina
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2018-05-01
Series:	Российский кардиологический журнал
Subjects:	endothelial dysfunction essential hypertension nitric oxide von willebrand factor score
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/2724
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Relation of smoking and endothelial dysfunction markers in systemic hypertension
by: V. I. Podzolkov, et al.
Published: (2018-10-01)

THE INVOLVEMENT OF ENDOTHELIAL DYSFUNCTION MARKERS IN THE PATHOGENESIS OF CHRONIC GLOMERULONEPHRITIS
by: T.V. Margieva, et al.
Published: (2006-03-01)

Endothelial Dysfunction Markers in Ovarian Cancer: VTE Risk and Tumour Prognostic Outcomes
by: Inês Guerra de Melo, et al.
Published: (2024-12-01)

Endothelial Dysfunction in Trauma: Pathogenesis, Clinical Significance, Diagnosis and Treatment
by: V. V. Matyukhin, et al.
Published: (2025-01-01)

THE STATE OF NITROXIDE PRODUCTION FUNCTION OF ENDOTHELIUM AND LEFT VENTRICLE HYPERTROPHY IN ARTERIAL HYPERTENSION
by: V. I. Podzolkov, et al.
Published: (2017-08-01)

Comparison of endothelial function in patients with Stage I-II arterial hypertension and stable angina, receiving various bradycardic agents and perindopril
by: L. L. Kirichenko, et al.
Published: (1970-01-01)

Vascular markers of cognitive dysfunction in patients with uncontrolled arterial hypertension
by: V. I. Podzolkov, et al.
Published: (2020-11-01)

Endothelial dysfunction in patients with various forms of congenital epidermolysis bullosa
by: V. I. Kornev, et al.
Published: (2022-11-01)

Dynamics of endothelial function violation in patients with arterial hypertension with moderate cardiovascular risk and antihypertensive therapy treatment influence
by: T. S. Turlyun
Published: (2016-08-01)

Markers of Endothelial Dysfunction: E-selectin, Endothelin-1 and von Willebrand Factor in Patients with Coronary Heart Disease, Including in Combination with Type 2 Diabetes Mellitus
by: A. V. Zhito, et al.
Published: (2020-01-01)

Vascular-type heterogeneity is associated with differential gene expression profiles of endothelial cells under shear stress
by: Allaura A. Cox, et al.
Published: (2025-05-01)

Correction of endothelial dysfunction and microcirculation disturbances in patients with essential arterial hypertension and Type 2 diabetes mellitus
by: N. V. Yakutina
Published: (2007-12-01)

Influence of von Willebrand factor on common pathophysiological mechanisms of cerebrovascular diseases and multiple sclerosis
by: I. A. Koltsov, et al.
Published: (2021-09-01)

Endothelial dysfunction in hypertension: cause or effect?
by: A. Yu. Gorshkov, et al.
Published: (2019-12-01)

Correction of Endothelial Dysfunction in Patients with Essential Hypertension when Using a Combination of Olmesartan/Lercanidipine and Zofenopril/Lercanidipine
by: O. V. Zimnitskaya, et al.
Published: (2016-11-01)

Relationship of Circulating Endothelial Cells, Endothelial Progenitor Cells, and Endothelial Dysfunction after High-Intensity Exercise: Role of Nitric Oxide
by: Rias Gesang Kinanti, et al.
Published: (2023-06-01)

Effects of a fixed-dose combination of ACE inhibitor and nondihydropyridine calcium antagonist on endothelial dysfunction in patients with essential arterial hypertension
by: O. D. Ostroumova, et al.
Published: (2010-04-01)

Advances in Research on the Release of von Willebrand Factor from Endothelial Cells through the Membrane Attack Complex C5b-9 in Sepsis
by: Liu Y, et al.
Published: (2025-05-01)

von Willebrand Factor (VWF) Inhibitors in Two Brothers with von Willebrand Disease: A Case Report
by: Claudia Djambas Khayat, et al.
Published: (2025-01-01)

Risk of endothelial dysfunction in streptozotocin-induced diabetic Sprague-Dawley rats: Nitric oxide in focus
by: M.L. Jidda J.M. Bunza M.K. Dallatu L.S. Bilbis A.J. Alhassan Muhammad Yelwa Gwarzo A.A. Ngaski A.F. Chiroma S.L. Kakako Maryam Kasimu B.M. Yale M. Kasimu S. Haruna K.A. Ogunwale A. K. Bello Ibrahim Kalle Kwaifa
Published: (2023-09-01)

Features of coronary heart disease in a cohort of tajik patients and the condition of the vascular endothelium in its different clinical forms
by: F. A. Shukurov, et al.
Published: (2024-06-01)

Study of the state of th vascular endothelium in various forms of coronary heart disease
by: F. A. Shukurov, et al.
Published: (2023-09-01)

Hemodynamic activation of von Willebrand factor in children with congenital heart diseases
by: K. A. Tokmakova, et al.
Published: (2024-11-01)

Intraindividual variability of von Willebrand factor and the need for repeated testing
by: Malene Helligsø Kirkeby, et al.
Published: (2025-05-01)

Arterial hypertension as a consequence of endothelial glycocalyx dysfunction: a modern view of the problem of cardiovascular diseases
by: M. M. Ziganshina, et al.
Published: (2022-10-01)

Endothelial dysfunction and apoptosis in the pathogenesis of cognitive impairment in patients with arterial hypertension
by: M. V. Ivanov, et al.
Published: (2009-02-01)

The functional state of endothelium at chronic hepatitis C
by: I. A. Bulatova, et al.
Published: (2009-06-01)

Prognostic value of von Willebrand factor in clinical practice
by: K. N. Grigoreva, et al.
Published: (2022-11-01)

Association of nitric oxide levels and lipid profile with endothelial dysfunction in type 2 diabetic patients
by: Hamza Algomizy, et al.
Published: (2024-10-01)

Dynamics of laboratory markers of endothelial dysfunction in patients with psoriatic arthritis under the influence of the interleukin-17A inhibitor netakimab
by: A. V. Petrov, et al.
Published: (2024-12-01)

Probing rare von Willebrand disease–causing mutations in the D4 and C-domains of von Willebrand factor
by: Golzar Mobayen, et al.
Published: (2025-05-01)

Dynamics of fibrotic and vascular endothelial dysfunction markers in elderly hypertensive patients after ischemic stroke receiving beta-blockers
by: O. A. Osipova, et al.
Published: (2022-01-01)

EFFICACY AND SAFETY OF FIXED COMBINATION OF LISINOPRIL AND HYDROCHLOROTHIAZIDE FOR MANAGEMENT OF VASCULAR DISORDERS IN PATIENTS WITH ARTERIAL HYPERTENSION
by: L. A. Haisheva
Published: (2016-01-01)

ACTIVITY MODULATION OF VARIOUS NITRIC OXIDE SYNTASES AS AN APPROACH TO ENDOTHELIAL DYSFUNCTION THERAPY
by: D. V. Kurkin, et al.
Published: (2022-05-01)

EFFECT OF FUROSTANOL GLYCOSIDES FROM CULTURED DIOSCOREA DELTOIDEA CELLS ON REGULATORY FUNCTION OF ENDOTHELIUM IN A RAT MODEL OF HYPOESTROGEN-INDUCED ENDOTHELIAL DYSFUNCTION
by: E. B. Artyushkova, et al.
Published: (2016-01-01)

Endothelial dysfunction markers in young patients with silent arterial hypertension
by: S. D. Mayanskaya, et al.
Published: (2004-12-01)

The Relationship of Endothelial Dysfunction with the Development of Diastolic Heart Failure in Patients with Hypertension
by: T. V. Kalinkina, et al.
Published: (2020-07-01)

Prognostic Significance of Markers of Endothelial Dysfunction in Case of Severe Combined Blunt Abdominal Trauma
by: V. V. Aleksandrov, et al.
Published: (2024-10-01)

Nitric oxide role and endothelial dysfunction development in diabetes mellitus
by: S. G. Dzugkoev, et al.
Published: (1970-01-01)

Clinical significance of diagnostic algorithm in detection of mild hemostasis disorders in women with menorrhagia
by: Đukić Svetlana M., et al.
Published: (2020-01-01)